CD (Suzhou) Biopharma Co., Ltd.
PrivateLast Round
Series A
May 1, 2023
Company Overview
CD (Suzhou) Biopharma Co., Ltd. is a biotechnology company that develops innovative immunotherapies for oncology, viral infections, and autoimmune diseases using its proprietary Bispecific Fusion Protein (BsFP) platform and IMmune-Enhanced (IME) cell technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CD (Suzhou) Biopharma Co., Ltd. Comparables
Compare CD (Suzhou) Biopharma Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Innovent Biologics | 82% | |
| Anwita Biosciences Inc. | 81% | |
| EpimAb Biotherapeutics | 77% |
CD (Suzhou) Biopharma Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 1, 2023 | ||||
| Angel | Jun 29, 2022 |
CD (Suzhou) Biopharma Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Proxima Ventures Ltd. | Angel |
| BioHub | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2023
Completed a Series A funding round.
- Jun 29, 2022
Proxima Ventures Ltd. led the funding round.
CD (Suzhou) Biopharma Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CD (Suzhou) Biopharma Co., Ltd.'s valuation, stock price, and market status.
Is CD (Suzhou) Biopharma Co., Ltd. a public or private company?
CD (Suzhou) Biopharma Co., Ltd. is a private company.
What is the current stock price of CD (Suzhou) Biopharma Co., Ltd.?
CD (Suzhou) Biopharma Co., Ltd. is a private company with no public stock price. Caplight tracks CD (Suzhou) Biopharma Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is CD (Suzhou) Biopharma Co., Ltd. worth (valuation)?
Valuation information for CD (Suzhou) Biopharma Co., Ltd. is not publicly available.
Can I buy CD (Suzhou) Biopharma Co., Ltd. stock?
CD (Suzhou) Biopharma Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CD (Suzhou) Biopharma Co., Ltd.'s last funding round?
CD (Suzhou) Biopharma Co., Ltd.'s most recent funding round was Series A on May 1, 2023.
Who are the main investors in CD (Suzhou) Biopharma Co., Ltd.?
Key investors in CD (Suzhou) Biopharma Co., Ltd. include Proxima Ventures Ltd., BioHub.
Will CD (Suzhou) Biopharma Co., Ltd. IPO soon?
No public IPO plans have been announced for CD (Suzhou) Biopharma Co., Ltd..
How can I track CD (Suzhou) Biopharma Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CD (Suzhou) Biopharma Co., Ltd.'s secondary market activity and sign up for updates.